OphtahliX Inc.
AboutInvestor InformationContact

About OphthaliX

About Us

 Company Leadership
 - Management
 - Board of Directors


Prof. Pnina Fishman, Ph.D., Chairman and Interim CEO
Prof. Fishman is the Chairman and Interim CEO of OphthaliX. Prof. Fishman is also the scientific founder and CEO of Can-Fite BioPharma and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center. Prof. Fishman is a very accomplished scientist and has authored or co-authored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as CEO of Mor Research Application (MRA), the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel, and the first clinical CRO in Israel. She was also involved in the establishment and served on the Board of Directors of several life sciences technology start-ups.
Itay Weinstein, Chief Financial Officer

Mr. Itay Weinstein is a Partner at Shimony C.P.A. and has been working there since 1999. Prior to that, Mr. Weinstein served as Auditor at Oren Horowitz. Mr. Weinstein holds a B.A. in economics and accounting from the Tel Aviv University, Israel and has been a licensed CPA since 1999. Mr. Weinstein is a board member of Uno Management and Consulting Ltd.


* Appointments are subject to completion of the acquisition of medical device technology company, Improved Vision Systems (I.V.S) Ltd, which is yet to occur. The acquisition is subject to a series of closing conditions. For more information click here.